Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.

Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G, Andrulis IL, Goodwin PJ.

Clin Genet. 2000 May;57(5):376-83.

PMID:
10852372
2.

[From gene to disease; from BRCA1 or BRCA2 to breast cancer].

Devilee P, Tollenaar RA, Cornelisse CJ.

Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2549-51. Review. Dutch.

PMID:
11191790
3.

The breast surgeon's role in BRCA1 and BRCA2 testing.

Matloff ET.

Am J Surg. 2000 Oct;180(4):294-8. Review.

PMID:
11113439
4.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
5.

[Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].

Ruiz-Flores P, Calderón-Garcidueñas AL, Barrera-Saldaña HA.

Rev Invest Clin. 2001 Jan-Feb;53(1):46-64. Review. Spanish.

PMID:
11332051
6.

[BRCA1 and BRCA2: mutations and other genetic changes--practical relevance].

Scherneck S, Hofmann W.

Chirurg. 1999 Apr;70(4):373-9. Review. German.

PMID:
10354832
7.

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rebbeck TR.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):100S-3S. Review.

PMID:
11060335
8.

BRCA1 and BRCA2--breast cancer susceptibility genes.

Hofmann W, Schlag PM.

J Cancer Res Clin Oncol. 2000 Sep;126(9):487-96. Review.

PMID:
11003560
9.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
10.

Clinical management of BRCA1- and BRCA2-associated breast cancer.

Karp SE.

Semin Surg Oncol. 2000 Jun;18(4):296-304. Review.

PMID:
10805951
11.

[Generic screening for breast cancer].

Ponti A, Giordano L.

Epidemiol Prev. 1999 Oct-Dec;23(4):369-71. Review. Italian.

PMID:
10730478
12.

Hereditary breast cancer in Jews.

Rubinstein WS.

Fam Cancer. 2004;3(3-4):249-57. Review.

PMID:
15516849
13.

Hereditary breast cancer.

Holli K.

Acta Oncol. 1999;38 Suppl 13:29-32. Review.

PMID:
10612493
14.

BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives.

Coughlin SS, Khoury MJ, Steinberg KK.

Am J Prev Med. 1999 Feb;16(2):91-8. Review.

PMID:
10343884
15.

[Genetic predisposition to breast cancer: a review in April 1998].

Stoppa-Lyonnet D.

Contracept Fertil Sex. 1999 Jul-Aug;27(7-8):517-20. Review. French.

PMID:
10495568
16.

A review of hereditary breast cancer: from screening to risk factor modification.

Warmuth MA, Sutton LM, Winer EP.

Am J Med. 1997 Apr;102(4):407-15. Review.

PMID:
9217624
17.

Breast & ovarian cancer. Issues in risk assessment.

Caro SW.

Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4. Review. No abstract available.

PMID:
10745719
18.

Psychological issues in genetic testing for breast cancer.

Carter CL, Hailey BJ.

Women Health. 1999;28(4):73-91. Review.

PMID:
10378346
19.

Psycho-social aspects of breast cancer susceptibility testing: a literature review.

Brédart A, Autier P, Audisio RA, Geragthy J.

Eur J Cancer Care (Engl). 1998 Sep;7(3):174-80. Review.

PMID:
9793009
20.

Screening and clinical implications for BRCA1 and BRCA2 mutation carriers.

Plon SE.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):377-87. Review.

PMID:
10819532

Supplemental Content

Support Center